6.93
0.23 (3.43%)
| Penutupan Terdahulu | 6.70 |
| Buka | 6.71 |
| Jumlah Dagangan | 361,500 |
| Purata Dagangan (3B) | 1,025,328 |
| Modal Pasaran | 5,577,330,176 |
| Harga / Jualan (P/S) | 8.28 |
| Harga / Buku (P/B) | 1.32 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 31 Mar 2025 |
| Margin Keuntungan | -64.29% |
| Margin Operasi (TTM) | -58.37% |
| EPS Cair (TTM) | -0.430 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 75.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.68% |
| Nisbah Semasa (MRQ) | 6.32 |
| Aliran Tunai Operasi (OCF TTM) | -178.83 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -344.38 M |
| Pulangan Atas Aset (ROA TTM) | -5.29% |
| Pulangan Atas Ekuiti (ROE TTM) | -8.02% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (HK) | Bercampur | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | OCUMENSION-B | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | -1.13 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| OCUMENSION-B | 6 B | - | - | 1.32 |
| GENSCRIPT BIO | 25 B | - | - | 0.720 |
| CARSGEN-B | 8 B | - | - | 6.98 |
| LEPU BIO-B | 8 B | - | - | 10.02 |
| JACOBIO-B | 5 B | - | - | 5.53 |
| BIODLINK-B | 3 B | - | 211.50 | 3.52 |
|
Ocumension Therapeutics is an ophthalmic pharmaceutical platform company identifying, developing, and commercializing ophthalmic therapies. It provides a pharmaceutical total solution to address unmet ophthalmic medical needs in China. Its product candidates include OT-401 (YUTIQ), OT-101, OT-301 (NCX 470), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-202, OT-503 (NCX 4251), OT-701, Ou Qin, Brimonidine tartrate eye drop, 0.5% moxifloxacin eye drop, OT-601-C, OT-302, OT-1301, T-1601, and OT-1602. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 53.19% |
| % Dimiliki oleh Institusi | 21.13% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |